Understanding the role of estrogen receptor expression in CVD risk in women with and without HIV
了解雌激素受体表达在感染和未感染 HIV 的女性 CVD 风险中的作用
基本信息
- 批准号:10013898
- 负责人:
- 金额:$ 17.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS/HIV problemAffectAgeAntiinflammatory EffectAntioxidantsAutomobile DrivingAwardBindingBiological MarkersBiologyBlood VesselsCardiacCardiovascular DiseasesCarotid ArteriesCellsCenters of Research ExcellenceClinicalClinical ResearchCohort StudiesCommunicable DiseasesDataData AnalysesDiseaseDisease ProgressionESR1 geneESR2 geneEstradiolEstrogen Receptor alphaEstrogen Receptor betaEstrogen ReceptorsEstrogensFibrosisFoundationsGene ExpressionGeneral PopulationGonadal Steroid HormonesHIVHIV InfectionsHIV SeronegativityImmuneImmune systemInflammationInflammatoryIschemic StrokeLaboratoriesLightLinkMacrophage ActivationMaster of ScienceMeasuresMenopausal StatusMenopauseMentored Patient-Oriented Research Career Development AwardMentorsMentorshipMethodsMyocardial InfarctionOrganParticipantPathogenesisPathway interactionsPatientsPeripheral Blood Mononuclear CellPersonsPlayPositioning AttributePremenopausePrevalenceProcessRecruitment ActivityRelative RisksResearchResearch PersonnelResearch ProposalsResearch TrainingResourcesRiskRisk FactorsRoleSamplingScientistSerumSex DifferencesSpecialized CenterTestingThickTimeTrainingTranslationsViralVisitWomanWomen’s Interagency HIV StudyWorkantiretroviral therapyarterial stiffnesscardioprotectioncardiovascular disorder riskcardiovascular risk factorcareercarotid intima-media thicknesscohortdesignearly experienceendothelial dysfunctionexperiencehigh riskinnovationlongitudinal analysismenprimary outcomeprospectiveprotein expressionreceptorreceptor expressionreceptor functionrecruitsecondary outcomeskillstraining opportunitytranslational scientisttrendvirologyyoung woman
项目摘要
PROJECT SUMMARY/ABSTRACT
With this K23 Mentored Patient-Oriented Research Career Development Award, I will develop the skills
necessary to become an independent clinician-scientist focused on the pathogenesis of end-organ disease in
women living with HIV (WLWH). My background in clinical Infectious Diseases and a Master of Science in
Clinical Research have provided a foundation for this work, which will leverage the resources of the Atlanta
Women’s Interagency HIV Study (WIHS) and Emory Specialized Center of Research Excellence (SCORE) on
Sex Differences. During this Award, I will be mentored by Dr. Igho Ofotokun, an HIV translational researcher
and PI of the Atlanta WIHS and SCORE, Dr. Gretchen Neigh, a basic scientist with experience in sex hormone
biology, and Dr. Arshed Quyyumi, a cardiologist and researcher with extensive experience in translational
vascular studies. I will complete advanced coursework in longitudinal data analysis, hands-on training in
laboratory methods to measure estrogen receptor gene expression and translation, vascular function, and
carotid artery wall thickness, and receive directed mentorship in CVD pathogenesis in women, sex hormone
biology, and HIV clinical research. HIV is a risk factor for CVD, and young women living with HIV (WLWH)
have an especially high risk for CVD compared to their HIV-uninfected counterparts. The mechanisms behind
this phenomenon are poorly understood, but we postulate that differences in estrogen activity may play a role.
Our prior work showed that CRP, a biomarker associated with CVD in the general population, does not predict
subclinical CVD progression in WLWH, as it does in HIV-uninfected women, suggesting that there is a different
mechanism driving the pathogenesis of CVD in WLWH, possibly related to estrogen activity. Estrogen affects
inflammatory pathways via its interactions with estrogen receptor (ER) and ER, which are encoded by the
genes ESR1 and ESR2, respectively. We found that the association between ESR1 and ESR2 expression on
PBMCs and carotid intima-media thickness differs by age and HIV status in women in WIHS. We hypothesize
that ESR1 and ESR2 expression and translation into ERα and ERβ is lower in WLWH than in HIV-negative
women, and reduced ESR1 and ESR2 expression and translation are associated with greater subclinical CVD
prevalence and progression. We propose a cohort study of virologically suppressed WLWH and at-risk HIV-
negative women with the following aims: 1) To determine the effect of HIV infection in ESR1 and ESR2
expression and translation on PBMCs over time, 2) To determine if ESR1 and ESR2 expression and
translation predicts prevalent subclinical CVD as measured by carotid artery wall thickness, endothelial
dysfunction and arterial stiffness, and 3) To determine the association between ESR1 and ESR2 expression
and translation in and subclinical CVD progression. Leveraging ongoing cohort studies that are actively
recruiting will greatly enhance the feasibility of these aims. Completion of these aims will separate me
scientifically from my mentors and position me to transition to independence as a clinician-scientist.
项目概要/摘要
通过这个 K23 指导的以患者为导向的研究职业发展奖,我将发展以下技能
有必要成为一名独立的临床医生科学家,专注于终末器官疾病的发病机制
感染艾滋病毒的女性 (WLWH) 我的临床传染病背景和理学硕士学位。
临床研究为这项工作奠定了基础,它将利用亚特兰大的资源
妇女机构间艾滋病毒研究 (WIHS) 和埃默里大学专业卓越研究中心 (SCORE)
性别差异。在这个奖项期间,我将受到艾滋病毒转化研究员 Igho Ofotokun 博士的指导。
亚特兰大 WIHS 和 SCORE 的 PI,Gretchen Neigh 博士,一位在性激素方面拥有丰富经验的基础科学家
生物学和 Arshed Quyyumi 博士是一位心脏病学家和研究员,在转化方面拥有丰富的经验
我将完成纵向数据分析的高级课程和实践培训。
测量雌激素受体基因表达和翻译、血管功能的实验室方法,以及
颈动脉壁厚度,并接受女性 CVD 发病机制、性激素的指导指导
生物学和 HIV 临床研究 HIV 是 CVD 的危险因素,以及感染 HIV 的年轻女性 (WLWH)。
与未感染艾滋病毒的捐赠者相比,他们患心血管疾病的风险特别高。
人们对这种现象知之甚少,但我们推测雌激素活性的差异可能发挥了作用。
我们之前的工作表明,CRP(一种与普通人群中 CVD 相关的生物标志物)并不能预测
WLWH 中的亚临床 CVD 进展与未感染 HIV 的女性一样,表明存在不同的情况
WLWH 中 CVD 发病机制的驱动机制,可能与雌激素活性的影响有关。
通过与雌激素受体 (ER)α 和 ERβ 的相互作用来调节炎症通路,雌激素受体 (ER)α 和 ERβ 是由
我们分别发现ESR1和ESR2基因表达之间的关联。
WIHS 女性的 PBMC 和颈动脉内膜中层厚度因年龄和 HIV 状况而异。
WLWH 中的 ESR1 和 ESR2 表达以及翻译成 ERα 和 ERβ 的水平低于 HIV 阴性者
女性,ESR1 和 ESR2 表达和翻译的减少与亚临床 CVD 的增加有关
我们提出了一项针对病毒学抑制的 WLWH 和高危 HIV 的队列研究。
阴性女性的目的如下: 1) 确定 HIV 感染对 ESR1 和 ESR2 的影响
随着时间的推移,PBMC 上的表达和翻译,2) 确定 ESR1 和 ESR2 表达和翻译是否
翻译可预测流行的亚临床 CVD(通过颈动脉壁厚度、内皮细胞厚度测量)
功能障碍和动脉僵硬度,以及 3) 确定 ESR1 和 ESR2 表达之间的关联
利用正在进行的队列研究积极进行亚临床CVD进展。
招募将大大提高这些目标的可行性,完成这些目标将使我分离。
科学地从我的导师那里获得帮助,使我能够过渡到作为一名临床医生科学家的独立地位。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Caitlin Moran其他文献
Caitlin Moran的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Caitlin Moran', 18)}}的其他基金
Understanding the role of estrogen receptor expression in CVD risk in women with and without HIV
了解雌激素受体表达在感染和未感染 HIV 的女性 CVD 风险中的作用
- 批准号:
10155590 - 财政年份:2020
- 资助金额:
$ 17.94万 - 项目类别:
Understanding the role of estrogen receptor expression in CVD risk in women with and without HIV
了解雌激素受体表达在感染和未感染 HIV 的女性 CVD 风险中的作用
- 批准号:
10630208 - 财政年份:2020
- 资助金额:
$ 17.94万 - 项目类别:
Understanding the role of estrogen receptor expression in CVD risk in women with and without HIV
了解雌激素受体表达在感染和未感染 HIV 的女性 CVD 风险中的作用
- 批准号:
10454785 - 财政年份:2020
- 资助金额:
$ 17.94万 - 项目类别:
相似国自然基金
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
年龄结构和空间分布对艾滋病的影响:建模、分析与控制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
随机噪声影响下具有年龄结构的布鲁氏菌病动力学行为与最优控制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
HIV risk and prevention behavior and the role of social support networks among precariously housed youth: A mixed-methods study
住房不稳定的青少年的艾滋病毒风险和预防行为以及社会支持网络的作用:混合方法研究
- 批准号:
10755078 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
INTEGRATING A TRANSDIAGNOSTIC PSYCHOLOGICAL INTERVENTION IN THE CARE FOR ADOLESCENTS AND YOUTH WITH HIV IN KENYA
将跨诊断心理干预纳入肯尼亚艾滋病毒感染青少年的护理中
- 批准号:
10675988 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
Affordable Robot-Based Assessment of Cognitive and Motor Impairment in People Living with HIV and HIV-Stroke
经济实惠的基于机器人的艾滋病毒感染者和艾滋病毒中风患者认知和运动障碍评估
- 批准号:
10751316 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
Adapting mHealth interventions to improve self-management of HIV and substance use among emerging adults in Zambia
采用移动医疗干预措施,改善赞比亚新兴成年人对艾滋病毒和药物滥用的自我管理
- 批准号:
10813460 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
Neurofunctional Mechanisms of Changes in Cognition and Motor Function in Aging with HIV and Parkinson's Disease
HIV 和帕金森病导致的衰老过程中认知和运动功能变化的神经功能机制
- 批准号:
10619383 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别: